BioStem Technologies, Inc. (BSEM) NASDAQ

Currency In USD

BioStem Technologies, Inc.

Address

4901 Northwest 17th Way

Fort Lauderdale, FL 33309

United States of America (the)

Phone

954 380 8342

Website

https://biostemtechnologies.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

March 17, 2015

Key Executives

Name	Title	Pay	Year Born
Jason Matuszewski	Chief Executive Officer, President, Secretary & Chairman	900,000	1987
Brandon Poe	Chief Financial Officer	330,428	1970
Michael Fortunato	Chief Accounting Officer	506,250	1968
Andrew Vanvurst	Chief Operating Officer & Director	630,000	1992
Barry J. Hassett	Chief Commercial Officer	0	1967
Noah Agron	Vice President of Corporate Finance & Strategy	0	N/A
Katherine Gorrell	Chief Legal & Compliance Officer	0	1977
David Woynarowski	Chief Medical Officer	0	N/A
Jeff Humke	Vice President of Human Resources	0	N/A
Larry Jones	Chief Revenue Officer	0	N/A
Irmgard Huber	International Medical Advisor & Interim Chief Medical Officer	0	N/A

Description

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.